The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: RS1 vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000330.4(RS1):c.330T>C (p.Cys110=)

CA226691

98940 (ClinVar)

Gene: RS1
Condition: X-linked retinoschisis
Inheritance Mode: X-linked inheritance
UUID: 1e9db832-f26c-487e-bd00-49a1b7b7f7c1
Approved on: 2025-05-19
Published on: 2025-05-20

HGVS expressions

NM_000330.4:c.330T>C
NM_000330.4(RS1):c.330T>C (p.Cys110=)
NC_000023.11:g.18644622A>G
CM000685.2:g.18644622A>G
NC_000023.10:g.18662742A>G
CM000685.1:g.18662742A>G
NC_000023.9:g.18572663A>G
NG_008475.1:g.224018A>G
NG_008659.3:g.37827T>C
ENST00000379984.4:c.330T>C
ENST00000379984.3:c.330T>C
ENST00000379989.6:c.2714-1385A>G
ENST00000379996.7:c.2714-1385A>G
ENST00000476595.1:n.821T>C
NM_000330.3:c.330T>C
NM_001037343.1:c.2714-1385A>G
NM_003159.2:c.2714-1385A>G
NM_001037343.2:c.2714-1385A>G
NM_003159.3:c.2714-1385A>G
More

Benign

Met criteria codes 3
BP7 BP4 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
X-linked Inherited Retinal Disease VCEP
The NM_000330.4(RS1):c.330T>C variant is a synonymous variant at amino acid 110. This variant is present in gnomAD v.4.1.0 at a frequency of 0.01431 among hemizygous individuals, with 5657 variant alleles / 395399 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.0002 (BA1). The splicing impact predictor SpliceAI gives a delta score of 0.00 for all predictive splice changes, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4). This silent variant c.330T>C causing a synonymous variant at codon 110 does not have an impact at splicing sites according to Splice AI, which predicts a delta score of 0.00 for all predictive splice changes which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP7). In summary, this variant is classified as benign for X-linked retinoschisis based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0: BA1, BP4, and BP7 (date of approval 01/24/2025).
Met criteria codes
BP7
This silent variant c.330T>C causing a synonymous variant at codon 110 does not have an impact at splicing sites according to Splice AI, which predicts a delta score of 0.00 for all predictive splice changes which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on RS1 splicing (BP7).
BP4
The splicing impact predictor SpliceAI gives a delta score of 0.00 for all predictive splice changes, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on RS1 splicing (BP4).
BA1
This variant is present in gnomAD v.4.1.0 at a frequency of 0.01431 among hemizygous individuals, with 5657 variant alleles / 395399 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.0002 (BA1).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.